Augmenting Growth Hormone to Ameliorate Nonalcoholic Fatty Liver Disease in Adolescents
Clinical trial NCT02726542 · COMPLETED
Trial details
- NCT number
- NCT02726542
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-03
- Primary completion
- 2020-04-02
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.